24-week regimen of bedaquiline, pretomanid, linezolid, and moxifloxacin bests standard-care treatment for rifampin-resistant tuberculosis Medha Baranwal22 Dec 2022 2:30 AM GMTStandard-care treatment was similarly efficacious when patients could receive it without adverse effects, according to findings from a two-stage,...
Prescribe Moxifloxacin cautiously among diabetics as it has QTc prolonging effect Medha Baranwal1 Jun 2022 4:15 AM GMTUK: Hyperglycaemia is a significant cause of QTc prolongation in type 1 diabetes (T1D) patients and the additional effect of a a QTc-prolonging drug...
New tuberculosis regimen shortens treatment to four months: Study Hina Zahid16 Jun 2021 3:30 AM GMTShortening the treatment time improves adherence, decreases costs to programs and decreases the burdens on patients themselves.USA: A 4-month...
Four-month rifapentine regimen for TB equally effective as 6-month standard regimen: NEJM Medha Baranwal6 May 2021 1:15 AM GMTUSA: The effectiveness of a 4-month rifapentine-based regimen containing moxifloxacin is noninferior to the standard 6-month regimen for the treatment...
Oral antibiotics alone noninferior to IV followed by oral antibiotics in appendicitis patients: JAMA Medha Baranwal13 Jan 2021 5:32 AM GMTFinland: Adults with uncomplicated acute appendicitis treated with oral antibiotics versus IV followed by oral antibiotics had almost equal treatment...
Shorter TB treatment regimen as effective as longer course: CDC Study Medha Baranwal23 Oct 2020 1:43 PM GMTUSA: A four-month daily treatment containing high-dose rifapentine with moxifloxacin is as effective as the currently recommended six-month daily...
